Meta-analysis of clinical trials comparing the efficacy and safety of liposomal cisplatin versus conventional nonliposomal cisplatin in nonsmall cell lung cancer (NSCLC) and squamous cell carcinoma of the head and neck (SCCHN)

BACKGROUND: While liposomal cisplatin has shown enhanced drug tolerability and higher targeting property as compared with the conventional cisplatin, the doubt remains whether lipoplatin could improve its anticancer efficacy. What's more, there is still no systematic evaluation of the safety pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Bei, Zeng, Min, Zeng, Jiawei, Feng, Jiafu, Yu, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257614/
https://www.ncbi.nlm.nih.gov/pubmed/30431590
http://dx.doi.org/10.1097/MD.0000000000013169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257614/
https://www.ncbi.nlm.nih.gov/pubmed/30431590
http://dx.doi.org/10.1097/MD.0000000000013169

Ejemplares similares